Cancer clinical trials in the region Provence-Alpes-Côte d'Azur
130 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 2
Kidney cancer
#NCT06099782
Surgery
Grade 3
Grade 4
Immunotherapy
Bispecific T-cell engager antibodies
Radiotherapy
Centre Léon Bérard (Lyon), CHU Caen Normandie (Caen), Clinique Chénieux (Limoges), Hôpital Bichat - Claude Bernard - AP-HP (Paris), Hôpital d'Instruction des Armées Sainte-Anne (Toulon)
Merck Sharp & Dohme LLC
Phase 2
Lung cancer
#NCT06099782
NSCLC (Non-Small Cell Lung Cancer)
Metastatic
Systemic Treatment-Naive
PDL1 Positive (>= 50%)
Immunotherapy
Immunotherapy
Bispecific T-cell engager antibodies
Centre Léon Bérard (Lyon), CHU Caen Normandie (Caen), Clinique Chénieux (Limoges), Hôpital Bichat - Claude Bernard - AP-HP (Paris), Hôpital d'Instruction des Armées Sainte-Anne (Toulon)
Merck Sharp & Dohme LLC
Phase 2
Lung cancer
#NCT05967689
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
EGFR
Systemic Treatment-Naive
Immunotherapy
Chemotherapy
Targeted therapy
Systemic Treatment-Naive
Centre Hospitalier Universitaire de Strasbourg - Nouvel Hopital Civil (Strasbourg), CHU Caen Normandie (Caen), Institut Curie - Paris (Paris), Centre Hospitalier Universitaire Dupuytren (Limoges), Centre Hospitalier Universitaire Laennec (Saint-Herblain) (and 4 more...)
Taiho Oncology
Phase 2
Lymphoma
#NCT05952037
B cell lymphoma
Waldenström lymphoma
None
Targeted therapy
Systemic Treatment-Naive
Institut Paoli-Calmettes (Marseille), Centre Hospitalier Universitaire de Clermont Ferrand (Clermont-Ferrand), Hôpital Pitié Salpêtrière - AP-HP (Paris), CHU Amiens-Picardie (site sud) (Amiens)
BeiGene
Phase 2
Lung cancer
#NCT05925530
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Systemic Treatment-Naive
EGFR
ALK
Immunotherapy
Chemotherapy
Targeted therapy
Car-T
Bispecific T-cell engager antibodies
Antibody Drug Conjugates (ADC)
Centre Hospitalier Universitaire de Grenoble (La Tronche), Hôpital de la Timone AP-HM (Marseille), Institut Curie - Paris (Paris), Centre Hospitalier Universitaire de Poitiers - Site de la Milétrie (Poitiers), Centre Hospitalier Universitaire de Montpellier - Site de Saint Eloi (Montpellier) (and 1 more...)
AstraZeneca
Phase 2
Rectal cancer
#NCT05723562
Locally Advanced
MSI/dMMR
Systemic Treatment-Naive
MSS
Surgery
Immunotherapy
Chemotherapy
Targeted therapy
Car-T
Bispecific T-cell engager antibodies
Radiotherapy
Centre Hospitalier Universitaire de Besançon (Besançon), Institut Paoli-Calmettes (Marseille), CHU de Rennes - Hôpital Pontchaillou (Rennes), CHU - Haut-lévêque - Bordeaux (Pessac), Hôpital Saint Antoine AP-HP (Paris)
GlaxoSmithKline
Phase 2
Lung cancer
#NCT05609578
NSCLC (Non-Small Cell Lung Cancer)
Non-squamous NSCLC
Locally Advanced
Metastatic
KRAS G12C
Systemic Treatment-Naive
PDL1 Positive (1% <= X < 25%)
PDL1 Positive (25% <= X < 50%)
Targeted therapy
Immunotherapy
Chemotherapy
Targeted therapy
Car-T
Bispecific T-cell engager antibodies
Hôpital Larrey (Toulouse ), Centre Hospitalier Intercommunal Créteil (Créteil Cedex), Hôpital Tenon AP-HP (Paris ), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Centre François Baclesse (Caen ) (and 5 more...)
Mirati Thérapeutique Inc.
Phase 2
Lung cancer
#NCT05565378
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
Systemic Treatment-Naive
PDL1 Positive (>= 50%)
EGFR
ALK
Immunotherapy
Centre Hospitalier de Cornouaille (Quimper), Centre Hospitalier Universitaire de Strasbourg - Nouvel Hopital Civil (Strasbourg), Centre Hospitalier Universitaire de Bordeaux (Bordeaux), CHU Caen Normandie (Caen), Hôpital de la Timone AP-HM (Marseille)
GlaxoSmithKline
Phase 2
Lung cancer
#NCT05403385
NSCLC (Non-Small Cell Lung Cancer)
Squamous NSCLC
Locally Advanced
Metastatic
Immunotherapy
EGFR
ALK
Systemic Treatment-Naive
CHU Caen Normandie (Caen), Centre Hospitalier Universitaire de Nantes (Nantes), Centre Hospitalier Intercommunal Créteil (Créteil Cedex), Centre Léon Bérard (Lyon), Hôpital de la Timone AP-HM (Marseille) (and 4 more...)
iTeos Belgique SA
Phase 2
Lung cancer
#NCT05325866
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
Immunotherapy
Chemotherapy
Targeted therapy
Systemic Treatment-Naive
Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ), Centre Hospitalier Universitaire de Besançon (Besançon), Centre Oscar Lambret (Lille), Institut Paoli-Calmettes (Marseille), Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite) (and 2 more...)
Amgen